Analysts Morgan Stanley downgraded Salesforce (CRM) to equal-weight and lowered target price to $185, citing insufficient AI transformation results
Morgan Stanley has downgraded Salesforce's stock, citing insufficient results from its AI initiatives, which raises concerns for investors about the company's growth potential.